Taxotere Related Clinical Trials
Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer [Active, not recruiting]
A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel. [Withdrawn]
ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-Small Cell Lung Cancer [Active, not recruiting]
Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer [Active, not recruiting]
Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric Adenocarcinoma [Terminated]
Biologic Correlative Taxotere/AC [Active, not recruiting]
Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer [Completed]
Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer [Completed]
A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer [Terminated]
Neoadjuvant Taxotere [Completed]
Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer [Recruiting]
Randomized Study of Docetaxel +/- ZD6474 in Metastatic TCC [Recruiting]
Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma [Recruiting]
Taxotere Plus Bevacizumab (AVF3110) [Recruiting]
Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer [Completed]
Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer [Recruiting]
E3 Breast Cancer Taxotere Combination [Active, not recruiting]
OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer [Active, not recruiting]
Concurrent Docetaxel/Carboplatin/Radiotherapy - Surgical Resection - Consolidation Taxotere/Carboplatin in Stage III Non-Small Cell Lung Cancer [Recruiting]
Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer [Recruiting]
The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC) [Recruiting]
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer [Completed]
Iressa Versus Docetaxel (Taxotere) [Completed]
Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere) [Completed]
Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer [Active, not recruiting]
Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer [Terminated]
Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer [Completed]
A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer [Recruiting]
Docetaxel With or Without AZD6244 in Melanoma [Recruiting]
Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer [Recruiting]
Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer [Recruiting]
Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients [Recruiting]
BIG 02/98 Docetaxel - Breast Cancer [Active, not recruiting]
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer [Recruiting]
Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer [Active, not recruiting]
Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors [Recruiting]
Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer [Recruiting]
Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers [Completed]
Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers [Completed]
Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck [Completed]
A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer [Not yet recruiting]
Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer [Terminated]
Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients [Recruiting]
Study of PX-866 and Docetaxel in Solid Tumors [Recruiting]
Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for c-Stage IB-II Non-Small Cell Lung Cancer (NSCLC) [Active, not recruiting]
Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes [Recruiting]
A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients [Completed]
Phenelzine Sulfate and Docetaxel for Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel [Recruiting]
Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine [Active, not recruiting]
Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma [Recruiting]
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer [Recruiting]
A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP, Polymeric Nanoparticle Formulation of Docetaxel, in Subjects With Advanced Solid Malignancies [Recruiting]
A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer [Recruiting]
Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patients [Recruiting]
TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer [Recruiting]
Oleandrin (Nerium Oleander) in Combination With Carboplatin and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer [Not yet recruiting]
Docetaxel Lipid Microsphere (DT-LM) for Injection in Chemotherapy Patients [Recruiting]
Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy [Recruiting]
GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer [Recruiting]
Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients [Recruiting]
Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer [Recruiting]
Pazopanib, Docetaxel, Prednisone Prostate [Recruiting]
A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients Previously Treated With Docetaxel [Recruiting]
A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab), TCL (Docetaxel, Carboplatin and Lapatinib) and the Combination of TCHL (Docetaxel,Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients. [Recruiting]
Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer [Active, not recruiting]
Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer [Recruiting]
Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas. [Recruiting]
A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer [Active, not recruiting]
Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer [Recruiting]
Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies [Active, not recruiting]
E3-Hormone Refractory Prostrate Cancer Taxotere Combination [Completed]
A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer [Active, not recruiting]
Docetaxel, Androgen Ablation Therapy, and External-Beam Radiation Therapy in Treating Patients With High-Risk Localized Prostate Cancer [Recruiting]
Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer
Taxotere/Temodar/Cisplatin Study in Melanoma Patients [Active, not recruiting]
Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix [No longer recruiting]
Effects Of GW572016 In Combination With Docetaxel (TAXOTERE) [Completed]
Avastin and Taxotere for Esophagogastric Cancer [Active, not recruiting]
Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer [Completed]
Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer [Completed]
Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate [No longer recruiting]
Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer [Recruiting]
Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer [No longer recruiting]
Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer [Recruiting]
Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer [Completed]
A Study of Docetaxel Monotherapy or DOXIL®/CAELYX® and Docetaxel in Patients With Advanced Breast Cancer [Active, not recruiting]
Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients [Recruiting]
Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer [Recruiting]
Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer [Active, not recruiting]
Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008 [Completed]
Ph II Rand:Bevacizumab + Docetaxel Vs Docetaxel Alone in Pts w/Malig Pleural Effusion Due to Adv NSCLC [Recruiting]
Phase II Trial of Licorice Root/Docetaxel in Hormone Refractory Prostate Cancer [Recruiting]
Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients [Recruiting]
Liposomal Doxorubicin and Docetaxel in Human Epidermal Growth Factor Receptor 2 (HER2) Negative Metastatic Breast Cancer [Recruiting]
Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma [Completed]
Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer [Recruiting]
Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC) [Recruiting]
Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer [Completed]
Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients [No longer recruiting]
Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer
UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer [Active, not recruiting]
|
